Rajesh V Iyer

Rajesh-V-Iyer-1-scaled-e1675149474207-blackwhite

Rajesh V Iyer
Scientist
rajesh.iyer@tigs.res.in

Education

  • Ph.D. from CSIR – Centre for Cellular and Molecular Biology (CCMB), Hyderabad/Jawharlal Nehru University, Delhi (2021)
  • M.Sc. in Biotechnology from Indian Institute of Technology (IIT), Roorkee (2010)

Experience

  • Project Scientist, Atal Incubation Centre – Centre for Cellular and Molecular Biology (CCMB), Hyderabad (2021 – 2022)
  • Junior Research Fellow, Indian Institute of Technology (IIT), Roorkee (2011 – 2012)

Expertise

  • mRNA Technology- Vaccines and Therapeutics
  • Molecular Biology
  • Mutation Biology
  • Synthetic Biology

Areas of Interest

  • Molecular Evolution
  • Microbial Genetics and Molecular Biology
  • Protein Biology
  • Bioinformatics

Honors and Awards

  • Awarded the DBT- Biotechnology Ignition Grant (BIG) in 2022
  • Development of first indigenous mRNA vaccine candidate for Covid-19 in India, as part of the project ‘mRNA platform for vaccines and biotherapeutics’ funded by Council for Scientific and Industrial Research (CSIR) India.
  • Cleared UGC-CSIR Junior Research Fellowship entrance exam in December 2009 with All India Rank 100 and June 2011 with All India Rank 54.
  • Qualified Joint Admission to M.Sc. entrance (IIT-JAM) exam in 2008 with All India Rank 34.
  • Recipient of Indian Academy of Sciences summer fellowship in the year 2009.

Publications

  • Antimicrobial resistance landscape in a metropolitan city context using open drain wastewater based metagenomic analysis. MedRxiv (2023) Manas Kumar Madhukar, Nirupama Singh, Rajesh V Iyer, Divya Tej Sowpati, Karthik Bharadwaj Tallapaka, Rakesh K Mishra, Shivranjani Chandrashekhar Moharir. doi: https://doi.org/10.1101/2023.12.01.23299290 2023
  • Overexpression of MutS impairs DNA mismatch repair and causes cell division defect in E.coli. (2020) V Rajesh Iyer, Shivranjani C Moharir, Satish Kumar. bioRxiv 2020.10.13.337683; doi: https://doi.org/10.1101/2020.10.13.337683
  • Isolation of a non-genomic origin fluoroquinolone responsive regulatory element using a combinatorial bioengineering approach. Nucleic Acids Res. Srivastava SK, Iyer VR, Ghosh T, Lambadi PR, Pathania R, Navani NK. Nucleic Acids Res. (2016) Mar 18;44(5):2451-61. doi: 10.1093/nar/gkw029. Epub 2016 Feb 2. PMID: 26837578; PMCID: PMC4797293.
  • Small RNAs of Pathogenic Bacteria: Not Small Enough to be Overlooked for Therapeutics. Iyer VR & Sharma, Rajnikant & Pathania, Ranjana & Navani, Naveen. (2012). Molecular and Cellular Pharmacology. 4. 17-30. 10.4255/mcpharmacol.12.02.